TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 1 filers reported holding TANGO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,581 | +337212.2% | 26,961 | 0.0% | 0.20% | +195.5% |
| Q2 2023 | $90 | -99.9% | 26,961 | 0.0% | 0.07% | -10.8% |
| Q1 2023 | $106,496 | -45.5% | 26,961 | 0.0% | 0.07% | -33.9% |
| Q4 2022 | $195,467 | +99.5% | 26,961 | 0.0% | 0.11% | +220.0% |
| Q3 2022 | $98,000 | -19.7% | 26,961 | 0.0% | 0.04% | -20.5% |
| Q2 2022 | $122,000 | -40.2% | 26,961 | 0.0% | 0.04% | -18.5% |
| Q1 2022 | $204,000 | -30.8% | 26,961 | 0.0% | 0.05% | +12.5% |
| Q4 2021 | $295,000 | -15.5% | 26,961 | 0.0% | 0.05% | -2.0% |
| Q3 2021 | $349,000 | – | 26,961 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $146,779,000 | 53.77% |
| TCG Crossover Management, LLC | 1,254,500 | $9,509,000 | 3.82% |
| Cormorant Asset Management, LP | 4,899,185 | $37,136,000 | 2.85% |
| Boxer Capital, LLC | 6,871,642 | $52,087,000 | 2.68% |
| Casdin Capital, LLC | 5,487,910 | $41,598,000 | 1.86% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $14,567,000 | 1.42% |
| Samsara BioCapital, LLC | 630,000 | $4,775,000 | 1.20% |
| TANG CAPITAL MANAGEMENT LLC | 468,750 | $3,553,000 | 0.71% |
| Southpoint Capital Advisors LP | 3,805,929 | $28,849,000 | 0.56% |
| HARVARD MANAGEMENT CO INC | 708,385 | $5,370,000 | 0.54% |